+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

C

Actively Recruiting

Researchers are conducting the RECOVER study, a prospective, non-interventional, single-center cohort study at Hochgebirgsklinik Davos, focusing on patients undergoing cardiac rehabilitation. The study aims to evaluate patient characteristics, rehabilitation strategies, predictors of recovery, and clinical outcomes during and after rehabilitation. It seeks to understand how factors like genetics, plasma, biomarkers, and comorbidities influence long-term outcomes to improve personalized treatment approaches in cardiac rehabilitation. Participants are patients referred for cardiac rehabilitation at Hochgebirgsklinik Davos who agree to join the study. The study will establish a comprehensive database and biobank to support detailed clinical assessments and long-term follow-up. There are no experimental treatments instead, patients receive standard cardiac rehabilitation care while data is collected for research. During the study, participants undergo extensive clinical evaluations, including phenotyping and assessments of quality of life, cognitive function, and functional capacity. Researchers will monitor outcomes such as cardiovascular mortality, heart attacks, strokes, hospitalizations, rehospitalizations, and other cardiovascular events at 1, 5, and 10 years after inclusion. The study plans long-term follow-up to gather detailed information on recovery and health status over many years.

Age: 18Years +All Genders
1 location
S

Actively Recruiting

Severe asthma is a chronic lung condition involving persistent airway inflammation, causing difficulty breathing and varying symptoms. This research aims to establish a detailed clinical register for patients with severe asthma across multiple centers in Switzerland to better understand the diseases characteristics, treatment patterns, and outcomes. The study focuses on tracking changes in asthma symptom control over time and gathering data on the diseases natural history and healthcare impact. Participants with severe asthma receiving care at specialized centers will be enrolled in this observational study. The registry will collect routine clinical data including lung function tests, blood analyses, asthma control assessments, medication use, and quality of life questionnaires. Follow-up visits occur at four months after starting specific therapies and annually for up to 15 years to monitor disease progression and treatment effects. During the study, participants undergo regular evaluations such as lung function tests including FVC and FEV1, exhaled nitric oxide measurements, blood gas analysis, and blood counts. Researchers will track exacerbations, healthcare usage, and mortality alongside symptom control scores. This long-term observation aims to improve understanding of severe asthma management and outcomes while ensuring thorough documentation of complex therapies like antibody treatments. The total duration of participation may be up to 15 years with repeated yearly assessments.

Age: 1Year +All Genders
10 locations